MTOR and malignant colon neoplasm: In this study, we have determined the anticancer activity of PP242 [19], a kinase inhibitor of mTOR and NVP-BEZ235 [20], a dual PI3K/mTOR inhibitor, in colon cancer cells, both in vitro and in vivo.